Search

Your search keyword '"Gautier, Jean‐Francois"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Gautier, Jean‐Francois" Remove constraint Author: "Gautier, Jean‐Francois"
221 results on '"Gautier, Jean‐Francois"'

Search Results

1. Dépistage et prise en charge du diabète de type 1 préclinique, stade 1–2. Prise de position d’experts français

2. Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes

4. Prévalence et description des réactions cutanées associées aux adhésifs des dispositifs technologiques du diabète dans une population adulte : résultats de l’étude CUTADIAB

5. Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants

7. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study

9. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

10. The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort

16. Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan®

22. Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis.

23. High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

24. Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases

29. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes

35. WED-245 Should specific cutoffs be used for diagnosing fibrotic MASH in patients with type 2 diabetes using FAST, MAST, MEFIB and FNI?

39. Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms

Catalog

Books, media, physical & digital resources